Immunotherapy for diabetic amyotrophy

Cochrane Database of Systematic Reviews

Volumn 2017, Issue 7, 2017, Pages 1-19

  Chan, Yee Cheun ^a   Lo, Yew Long ^b   Chan, Edwin S Y ^c  

^a NATIONAL UNIVERSITY HOSPITAL   (Singapore)

^b SINGAPORE GENERAL HOSPITAL   (Singapore)

^c Singapore Clinical Research Institute Pte   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

METHYLPREDNISOLONE; PLACEBO; NEUROPROTECTIVE AGENT;

ARTICLE; DIABETES MELLITUS; HUMAN; IMMUNOTHERAPY; LIMB WEAKNESS; LOWER LIMB; MULTICENTER STUDY (TOPIC); MUSCLE ATROPHY; PAIN; PLACEBO EFFECT; PLEXUS PARESIS; PRIORITY JOURNAL; RADICULOPATHY; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYSTEMATIC REVIEW; DIABETIC NEUROPATHIES; INTRAVENOUS DRUG ADMINISTRATION; PROCEDURES;

DIABETIC NEUROPATHIES; HUMANS; IMMUNOTHERAPY; INJECTIONS, INTRAVENOUS; METHYLPREDNISOLONE; NEUROPROTECTIVE AGENTS;

EID: 85025840801     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD006521.pub4     Document Type: Article

References (31)

1. * Dyck PJB, O'Brien P, Bosch EP, Grant I, Burns T, Windebank A, et al. The multi-centre double-blind controlled trial of IV methylprednisolone in diabetic lumbosacral radiculoplexus neuropathy. Neurology 2006;66 (5, Suppl 2):A191
2. Bhanushali MJ, Muley SA. Diabetic and non-diabetic lumbosacral radiculoplexus neuropathy. Neurology India 2008;56(4):420-5.
3. BradleyWG, Chad D, Verghese JP, LiuHC, Good P, Gabbai AA, et al. Painful lumbosacral plexopathy with elevated erythrocyte sedimentation rate: a treatable inflammatory syndrome. Annals of Neurology 1984;15(5):457-64.
4. Chokroverty S, Reyes MG, Rubino FA, Tonaki H. The syndrome of diabetic amyotrophy. Annals of Neurology 1977;2(3):181-94.
5. Coppack SW, Watkins PJ. The natural history of diabetic femoral neuropathy. Quarterly Journal of Medicine 1991;79 (288):307-13.
6. Dyck PJ, Sherman WR, Hallcher LM, Service FJ, O'Brien PC, Grina LA, et al. Human diabetic endoneurial sorbitol, fructose, and myo-inositol related to sural nerve morphometry. Annals of Neurology 1980;8(6):590-6.
7. Dyck PJ, Kratz KM, Karnes JL, Litchy WJ, Klein R, Pach JM, et al. The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study. Neurology 1993;43(4):817-24.
8. Dyck PJ, Litchy WJ, Kratz KM, Suarez GA, Low PA, Pineda AA, et al. A plasma exchange versus immune globulin infusion trial in chronic inflammatory demyelinating polyradiculoneuropathy. Annals of Neurology 1994;36(6): 838-45.
9. Dyck PJ, Norell JE, Dyck PJ. Microvasculitis and ischemia in diabetic lumbosacral radiculoplexus neuropathy. Neurology 1999;53(9):2113-21.
10. Dyck PJ, Engelstad J, Norell J, Dyck PJ. Microvasculitis in non-diabetic lumbosacral radiculoplexus neuropathy (LSRPN): similarity to the diabetic variety (DLSRPN). Journal of Neuropathology and Experimental Neurology 2000; 59(6):525-38.
11. Dyck PJ, Windebank AJ. Diabetic and nondiabetic lumbosacral radiculoplexus neuropathies: new insights into pathophysiology and treatment. Muscle & Nerve 2002;25 (4):477-91.
12. Ellenberg M. Diabetic neuropathic cachexia. Diabetes 1974; 23(5):418-23.
13. Garces-Sanchez M, Laughlin RS, Dyck PJ, Engelstad JK, Norell JE, Dyck PJ. Painless diabetic motor neuropathy: a variant of diabetic lumbosacral radiculoplexus neuropathy?. Annals of Neurology 2011;69(6):1043-54.
14. Grant IA, O'Brien P, Dyck PJ. Neuropathy tests and normative results. In: Dyck PJ, Thomas PK editor (s). Diabetic Neuropathy. Philadelphia: Saunders, 1999: 123-41.
15. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions 5.1.0 (updated February 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.
16. Jaradeh SS, Prieto TE, Lobeck LJ. Progressive polyradiculoneuropathy in diabetes: correlation of variables and clinical outcome after immunotherapy. Journal of Neurology, Neurosurgery, and Psychiatry 1999;67(5):607-12.
17. Kawamura N, Dyck PJ, Schmeichel AM, Engelstad JK, Low PA, Dyck PJ. Inflammatory mediators in diabetic and non-diabetic lumbosacral radiculoplexus neuropathy. Acta Neuropathologica 2008;115(2):231-9.
18. Kelkar P, Masood M, Parry GJ. Distinctive pathologic findings in proximal diabetic neuropathy (diabetic amyotrophy). Neurology 2000;55(1):83-8.
19. Kilfoyle D, Kelkar P, Parry GJ. Pulsed methylprednisolone is a safe and effective treatment for diabetic amyotrophy. Journal of Clinical Neuromuscular Disease 2003;4(4): 168-70.
20. Kleyweg RP, van der Meche FG, Schmitz PI. Interobserver agreement in the assessment of muscle strength and functional abilities in Guillain-Barré syndrome. Muscle & Nerve 1991;14(11):1103-9.
21. Krendel DA, Costigan DA, Hopkins LC. Successful treatment of neuropathies in patients with diabetes mellitus. Archives of Neurology 1995;52(11):1053-61.
22. Llewelyn JG, Thomas PK, King RH. Epineurial microvasculitis in proximal diabetic neuropathy. Journal of Neurology 1998;245(3):159-65.
23. O'Hare JA, Abuaisha F, Geoghegan M. Prevalence and forms of neuropathic morbidity in 800 diabetics. Irish Journal of Medical Science 1994;163(3):132-5.
24. O'Neill BJ, Flanders AE, Escandon SL, Tahmoush AJ. Treatable lumbosacral polyradiculitis masquerading as diabetic amyotrophy. Journal of the Neurological Sciences 1997;151(2):223-5.
25. Pascoe MK, Low PA, Windebank AJ, Litchy WJ. Subacute diabetic proximal neuropathy. Mayo Clinic Proceedings 1997;72(12):1123-32.
26. Said G, Goulon-Goeau C, Lacroix C, Moulonguet A. Nerve biopsy findings in different patterns of proximal diabetic neuropathy. Annals of Neurology 1994;35(5):559-69.
27. Sugimoto K, Murakawa Y, Sima AA. Diabetic neuropathy-- a continuing enigma. Diabetes/Metabolism Research and Reviews 2000;16(6):408-33.
28. Tamburin S, Zanette G. Intravenous immunoglobulin for the treatment of diabetic lumbosacral radiculoplexus neuropathy. Pain Medicine (Malden, Mass.) 2009;10(8): 1476-80.
29. Van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJ, van Gijn J. Interobserver agreement for the assessment of handicap in stroke patients. Stroke 1988;19(5):604-7.
30. Zochodne DW, Isaac D, Jones C. Failure of immunotherapy to prevent, arrest or reverse diabetic lumbosacral plexopathy. Acta Neurologica Scandinavica 2003;107(4):299-301.
31. Chan YC, Lo YL, Chan ESY. Immunotherapy for diabetic amyotrophy. Cochrane Database of Systematic Reviews 2009, Issue 3. [DOI: 10.1002/14651858.CD006521.pub2]